Dew, In the generic area, just wondering if you expect consolidation to contuinue, and if so, who might be next to be acquired? Also, in addition to Teva, any generic companies you particularly like for the longer term? I've been generally considering the whole group as an attractive buy/hold. Thanks.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.